Muth et al. reported that inhibitor of CD27 on regulatory T cells and the application of PD-1 inhibitors synergistically improve the infiltration and functionality of CD8+ T cells in the tumor microenvironment [65]. The gene discussed is CD27; the disease is neoplasm.